Mild Cognitive Impairment.
10.17340/jkna.2016.34.3.1
- Author:
Eungseok OH
1
;
Ae Young LEE
Author Information
1. Department of Neurology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea. aelee@cnu.ac.kr
- Publication Type:Review
- Keywords:
Mild cognitive impairment;
Dementia;
Biomarkers;
Management
- MeSH:
Aging;
Biomarkers;
Classification;
Dementia;
Diagnostic Tests, Routine;
Mild Cognitive Impairment*;
Neuroimaging;
Prevalence;
Prognosis;
Risk Factors
- From:Journal of the Korean Neurological Association
2016;34(3):167-175
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Mild cognitive impairment (MCI) is an intermediate cognitive state between normal aging and dementia. It has disparate features in activities of daily life which is interfered notably in dementia. Recently, there have been consistent reports of MCI which is predementia, however significant controversy exist. In this review, we make out the diagnostic criteria, classification, risk factor, prevalence, diagnostic test including neuroimaging and biomarkers, management, and prognosis of MCI. This review will cover current knowledge and future directions on MCI.
